Honokiol Analogs: A Novel Class of Anticancer Agents Targeting Cell Signaling Pathways and Other Bioactivities
Citations Over TimeTop 10% of 2013 papers
Abstract
Honokiol (3,5-di-(2-propenyl)-1,1-biphenyl-2,2-diol) is a natural bioactive neolignan isolated from the genus Magnolia. In recent studies, honokiol has been observed to have anti-angiogenic, anticancer, anti-inflammatory, neuroprotective and GABA-modulating properties in vitro and in preclinical models. Honokiol and its analogs target multiple signaling pathways including NF-κB, STAT3, EGFR, mTOR and caspase-mediated common pathway, which regulate cancer initiation and progression. Honokiol and its targets of action may be helpful in the development of effective analogs and targeted cancer therapy. In this review, recent data describing the molecular targets of honokiol and its analogs with anticancer and some other bioactivities are discussed.
Related Papers
- → Targeting apoptosis pathways in cancer with magnolol and honokiol, bioactive constituents of the bark of <i>Magnolia officinalis </i>(2011)52 cited
- HEAT-INDUCED DEGRADATION OF MAGNOLOL AND HONOKIOL IN SUPERCRITICAL FLUID CO_2 EXTRACTION OF CORTEXMAGNOLIA OFFICINALIS (HOUPO)(2002)
- Determination of Magnolol and Honokiol in the Herb of Magnolia officinalis by Fluorescence Spectrophotometry(2004)
- Optimization of Extraction Technology of Magnolol and Honokiol from the Leaves of Magnolia officinalis Rehd.et Wils. through Orthogonal Test(2012)
- Quantitative Analysis of the Content of Magnolol and Honokiol in the Leaf of Magnolia Officinalis Produced in Hubei Enshi(2012)